?:authorAffiliation
|
-
[\'Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.\', \'Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.\', \'Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK. Julie.douthwaite@astrazeneca.com.\', \'In Vivo Expressed Biologics, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK. Julie.douthwaite@astrazeneca.com.\', \'Charles River Laboratories, Chesterford Research Park, Saffron Walden, CB10 1XL, UK.\', \'Division of Virology, Department of Pathology, Addenbrooke\'s Hospital, Cambridge, UK.\', \'Biologics Engineering, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.\', \'Animal Science and Technologies, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.\', \'Facilities Management, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.\', \'Clinical Operations, Late-Stage Development, Oncology R&D, AstraZeneca, Cambridge, UK.\', \'Department of Medicine, University of Cambridge, Cambridge, UK.\', \'BiologIC Technologies Ltd., Soham, UK.\', \'Oral Product Development, Pharmaceutical Technology and Development, Operations, AstraZeneca, Macclesfield, UK.\', \'Wellcome Sanger Institute, Hinxton, UK.\', \'BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.\']
|